伦敦帝国理工学院的科学家开发了用于诊断胶质母细胞瘤的血液测试，这可能会彻底改变早期检测和治疗。 Scientists at Imperial College London develop blood test for diagnosing glioblastoma, potentially revolutionizing early detection and treatment.
血液测试可能很快就能诊断出患有最致命的脑癌的患者，使他们免于接受侵入性手术。 A blood test may soon diagnose patients with the deadliest form of brain cancer, sparing them from undergoing invasive surgery. 伦敦帝国理工学院的科学家开发了一种诊断神经胶质瘤的新技术，包括胶质母细胞瘤，这是成人中最常见的高级脑肿瘤类型。 Scientists at Imperial College London have developed a new technique to diagnose glial tumors, including glioblastoma, the most common type of high-grade brain tumor in adults. 该测试发表在《国际癌症杂志》上，可能会彻底改变这种危及生命的疾病的治疗方法，从而实现早期发现和风险较低的手术。 The test, published in the International Journal of Cancer, could potentially revolutionize the treatment of this life-threatening condition, enabling early detection and less risky procedures.